432
Participants
Start Date
April 7, 2016
Primary Completion Date
October 18, 2023
Study Completion Date
October 18, 2023
cemiplimab
Royal North Shore Hospital, St Leonards
Peter MacCallum Cancer Centre, Melbourne
Royal Brisbane & Women's Hospital, Herston
Adelaide Cancer Centre, Kurralta Park
Sir Charles Gairdner Hospital, Nedlands
New York University, New York
Memorial Sloan Kettering Cancer Center, New York
Charitè Campus Mitte, Berlin
Hopitaux de La Timone, Marseille
C.H. Regional Reina Sofia - PPDS, Córdoba
University of Rochester Medical Center, Rochester
Andreas Sygros Hosptial-University of Athen, Athens
Penn State Hershey Medical Center, Hershey
St. Luke's Hematology Oncology Specialists, Easton
CHU Dijon Bourgogne, Dijon
Universitatsklinikum Schleswig-Holstein, Kiel
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Dermatology and Laser Center of Charleston, Charleston
Medizinische Hochschule Hannover, Hanover
Hôpital Saint-André, Bordeaux
Mount Sinai Comprehensive Cancer Center, Miami Beach
H. Lee Moffitt Cancer Center, Tampa
CHRU Grenoble, Grenoble
Hospital Universitario Marques de Valdecilla, Santander
Norton Cancer Institute, Louisville
Centre Hospitalier Universitaire de Nantes, Nantes
Cleveland Clinic, Cleveland
Universitätsklinikum Essen, Essen
Fundacion Instituto Valenciano de Oncología, Valencia
Barbara Ann Karmanos Cancer Institute, Detroit
Hôpital Claude Huriez, Lille
Northwestern University, Chicago
St. Louis University, St Louis
Washington University in St. Louis, St Louis
Nebraska Methodist Hospital, Omaha
Centre Hospitalier Lyon Sud, Pierre-Bénite
Universitätsklinikum Tübingen, Tübingen
Hopital Cochin, Paris
Hôpital Saint Louis, Paris
MD Anderson Cancer Center, Houston
University of Colorado, Denver, Aurora
LMU Klinikum der Universität München, Munich
Huntsman Cancer Institute, Salt Lake City
University of Arizona Cancer Center, Phoenix
Mayo Clinic, Phoenix
University of California, Los Angeles, Los Angeles
City of Hope Hospital, Duarte
University of California, San Diego, San Diego
Hopital Avicenne, Bobigny
Stanford University, Redwood City
Institut Gustave Roussy, Villejuif
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
The Canberra Hospital, Garran
Gosford Hospital, Gosford
Calvary Mater Newcastle, Waratah
Princess Alexandra Hospital, Woolloongabba
Border Medical Oncology, Wodonga
Hospital de Clinicas de Porto Alegre, Porto Alegre
Liga Paranaense de Combate Ao Cancer - Hospital Erasto Gaertner, Curitiba
Fundação São Francisco Xavier-Hospital Márcio Cunha, Ipatinga
Animi, Lages
Fundação Antônio Prudente - AC Camargo Câncer Center, São Paulo
Instituto do Cancer do Estado de São Paulo ICESP, São Paulo
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Napoli
Istituto Oncologico Veneto - I.R.C.C.S., Padua
ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia, Brescia
Ospedale San Salvatore, L’Aquila
Istituto Europeo Di Oncologia, Milan
Fondazione Policlinico Universitario A Gemelli, Roma
Universitätsklinikum Carl Gustav Carus, Dresden
SRH Wald-Klinikum Gera, Gera
ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Hospital Clinic de Barcelona, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Universitario Germans Trias i Pujol, Barcelona
Regeneron Pharmaceuticals
INDUSTRY